Aribio Holdings아리바이오홀딩스
290690 · KOSDAQ · ₩290690 · 아리바이오홀딩스
₩2,685▼ ₩15 (0.56%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 12.6% | 11.2% | 12.0% | 18.2% | 14.9% | 25.0% |
| Operating margin | −19.1% | −17.6% | −13.1% | 0.9% | −7.7% | 7.2% |
| Net margin | 32.4% | −20.2% | −80.8% | −11.2% | −7.7% | 5.9% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +8.1% | −24.5% | −15.3% | +7.0% | −20.2% | — |
| Operating income growth | −17.8% | −1.5% | −1,383.7% | +111.9% | −185.5% | — |
| Net income growth | +273.9% | +81.2% | −511.8% | −54.6% | −204.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 13.1% | −9.1% | −58.2% | −12.7% | −9.5% | 8.7% |
| Return on assets | 7.9% | −6.0% | −29.5% | −5.9% | −6.1% | 5.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 73.0% | 55.8% | 49.7% | 156.6% | 57.8% | 54.1% |
| Net debt to equity | 48.9% | 39.4% | 35.6% | 96.2% | 12.1% | 22.5% |
| Current ratio | 49.6% | 42.7% | 95.7% | 57.6% | 124.3% | 107.7% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Aribio Holdings / 아리바이오홀딩스 / 290690 / KRX:290690
Source: KRX statistical information